Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Interest Expenses (2022 - 2025)

Pliant Therapeutics (PLRX) has disclosed Interest Expenses for 4 consecutive years, with $136000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 83.69% to $136000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 15.38% decrease, with the full-year FY2025 number at $2.6 million, down 15.38% from a year prior.
  • Interest Expenses was $136000.0 for Q4 2025 at Pliant Therapeutics, down from $815000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $877000.0 in Q3 2024 to a low of $136000.0 in Q4 2025.
  • A 4-year average of $509466.7 and a median of $321000.0 in 2023 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: soared 176.66% in 2024, then plummeted 83.69% in 2025.
  • Pliant Therapeutics' Interest Expenses stood at $317000.0 in 2022, then grew by 1.26% to $321000.0 in 2023, then skyrocketed by 159.81% to $834000.0 in 2024, then tumbled by 83.69% to $136000.0 in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Interest Expenses are $136000.0 (Q4 2025), $815000.0 (Q3 2025), and $809000.0 (Q2 2025).